GSK, a London-based FTSE 100 pharmaceutical company, has temporarily suspended certain diversity, equity and inclusion (DEI) initiatives for its UK employees. This decision stems from the company’s interpretation of US regulatory requirements. The US is GSK’s largest market.
The Guardian reported that the company has also revised its website, removingissued